Top 10 Pharmaceuticals markets in China

The fastest-growing and largest of the 20 sized Pharmaceuticals markets in China, 2023 to 2033, with active clinical trials.

Fastest-growing Pharmaceuticals markets in China

Top 10 fastest-growing Pharmaceuticals markets in China, by CAGR 2023 to 2033
#Market20232033 (projected)CAGRActive trials
1 Biosimilars $3 Bn$30.9 Bn 26.4%34
2 Cell Based Immunotherapy $1.3 Bn$11.9 Bn 24.5%5,435
3 Cannabidiol (CBD) $1.8 Bn$9.5 Bn 18.3%9
4 Cannabis $2.7 Bn$11 Bn 15%5
5 Atopic Dermatitis Drugs $903 Mn$3.3 Bn 13.7%73
6 Oncology/Cancer Drugs $14.2 Bn$36.6 Bn 9.9%7,323
7 Anti-Aging $7.1 Bn$17.7 Bn 9.6%146
8 Diabetes Management $6.3 Bn$14.3 Bn 8.6%399
9 Alzheimer Drugs $403 Mn$894 Mn 8.3%148
10 Contraceptives Drugs $2 Bn$4.5 Bn 8.3%0

Largest Pharmaceuticals markets in China

Top 10 largest Pharmaceuticals markets in China, by 2023 size
#Market20232033 (projected)CAGRActive trials
1 Oncology/Cancer Drugs $14.2 Bn$36.6 Bn 9.9%7,323
2 Anti-Aging $7.1 Bn$17.7 Bn 9.6%146
3 Diabetes Management $6.3 Bn$14.3 Bn 8.6%399
4 Gastrointestinal Drugs $4.3 Bn$7.8 Bn 6.1%2,538
5 Asthma & COPD Drugs $4 Bn$6.8 Bn 5.5%175
6 Biosimilars $3 Bn$30.9 Bn 26.4%34
7 Cannabis $2.7 Bn$11 Bn 15%5
8 HIV Drugs $2.4 Bn$4.9 Bn 7.3%30
9 Contraceptives Drugs $2 Bn$4.5 Bn 8.3%0
10 Cancer Supportive Care Drugs $2 Bn$3.6 Bn 6.2%526

2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.

Quick answers

What is the fastest-growing Pharmaceuticals market in China?

Biosimilars grows fastest, at 26.4% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (24.5%).

What is the largest Pharmaceuticals market in China?

Oncology/Cancer Drugs is the largest, worth about $14.2 Bn in 2023 and $36.6 Bn by 2033 (projected).

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.